Expert.ai recently introduces its Insight Engine for Life Sciences, aiming to enhancing the management and analysis of data in drug development.
The engine is specifically designed to refine the processing of scientific and biomedical information, crucial as the industry seeks to hasten the development of new medications and the management of clinical trials.
Christophe Aubry, Head of Life Sciences & Healthcare North America at expert.ai, commented on the technology's role, saying,
"The complexity of biomedical data, coupled with the dynamic nature of the Pharma and Life Sciences sector, necessitates advanced tools that can manage and utilize information efficiently and on a large scale."
Additionally, the Insight Engine integrates global clinical trials, proprietary scientific articles, and public resources to streamline drug discovery and clinical trial design.
It supports essential functions such as Competitive Intelligence, Clinical Trial Design Optimization, Intellectual Property Protection, and Research Intelligence, significantly enhancing the efficiency and outcomes of research and development in the life sciences.
The tool not only provides direct access to detailed, relevant data but also enhances the capacity to engage with emerging trends and research findings.
For example, it allows research teams to swiftly identify suitable trials and compare protocols, optimizing trial designs and potentially reducing patient and site burdens.
Conclusion
As a finalist at the upcoming Bio-IT World "Best of Show" Awards, expert.ai will showcase the capabilities of its Insight Engine at the Bio-IT World Conference & Expo in Boston.
The platform showcases Expert.ai's commitment to crafting solutions that address intricate language challenges in various sectors, including life sciences, through the use of sophisticated hybrid AI technologies.
Expert.ai continues to be an essential partner for enterprises seeking to harness AI to drive substantial improvements in pharmaceutical research and development.
